Island Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Island Pharmaceuticals has a total shareholder equity of A$1.5M and total debt of A$422.0K, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are A$2.6M and A$1.0M respectively.
Belangrijke informatie
27.8%
Verhouding schuld/eigen vermogen
AU$421.97k
Schuld
| Rente dekkingsratio | n/a |
| Contant | AU$1.66m |
| Aandelen | AU$1.52m |
| Totaal verplichtingen | AU$1.05m |
| Totaal activa | AU$2.56m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: ILA's short term assets (A$2.6M) exceed its short term liabilities (A$1.0M).
Langlopende schulden: ILA has no long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ILA has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if ILA's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: ILA has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: ILA is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.